2023, Number 1
<< Back Next >>
Bol Clin Hosp Infant Edo Son 2023; 40 (1)
Sacrococcygeal teratoma. Case report
Rochín-Benoit A, Rascón-Alcántar A, Pérez-Borbón G
Language: Spanish
References: 8
Page: 28-31
PDF size: 298.04 Kb.
ABSTRACT
Sacrococcygeal teratoma is the most common extragonadal
germ cell tumor in newborns and infants. It
occurs in 1 in 40,000 births, and the male-female ratio
is approximately 1:3. Risk factors related to prognosis
include tumor size, growth rate, histologic type, and
extragonadal tumor component. Sacrococcygeal teratoma
is thought to arise through epigenetic reprogramming
of the first primordial germ cells to migrate
from the yolk sac to the gonadal ridges. For this type
of tumors, it is reasonable to consider a cesarean section
depending on the size of the tumor, thus avoiding
tumor rupture, tumor bleeding, and difficulty at delivery.
REFERENCES
Virchow R. Uber die sacralgeschwulst des schliewenerkindes. € Berl. Klin. Wochenschr. 1869; 6: 193.
Taguchi T. Sacrococcygeal teratoma: Nationwidesurvey and guidelines. Pediatr Int. 2019 Jul; 61(7):633.
Yoneda A, Usui N, Taguchi T, et al. Impact of thehistological type on the prognosis of patients withprenatally diagnosed sacrococcygeal teratomas:The results of a nationwide Japanese survey. PediatrSurg Int. 2013; 29: 1119-25.
Baró AM, Pérez SP, Costa MM, Heredia CL, AzuaraLS, Juanos JL, Lapiedra MZ. Sacrococcygeal teratomawith preterm delivery: a case report. J MedCase Rep. 2020 Jun 19; 14(1): 72.
Phi JH. Sacrococcygeal Teratoma: A Tumor at theCenter of Embryogenesis. J Korean NeurosurgSoc. 2021 May; 64(3): 406-413.
Zheng XQ, Yan JY, Xu RL, Wang XC, Chen X, HuangKH. A Clinical Analysis of the Diagnosis and Treatmentof Fetal Sacrococcygeal Teratomas. CancerManag Res. 2020 Dec 23; 12: 13185-13193.
Umino S, Tajiri T, Usui N, Tamura M, Sago H, Ono S,Nosaka S, Yoneda A, Souzaki R, Higashi M, SakaiK, Takahashi K, Sugiura T, Taguchi T. Japanese clinicalpractice guidelines for sacrococcygeal teratoma,2017. Pediatr Int. 2019 Jul; 61(7): 672-678.
Schneider DT, Wessalowski R, Calaminus G, et al.Treatment of recurrent malignant sacrococcygealgerm cell tumors: Analysis of 22 patients registeredin the German protocols MAKEI 83/86, 89, and 96.J Clin Oncol. 2001; 19: 1951-60.